Literature DB >> 545640

Antileishmanial activity of selected compounds in dogs experimentally infected with Leishmania donovani.

W L Chapman, W L Hanson, V B Waits, K E Kinnamon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 545640

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN： 0036-4665            Impact factor:   1.846


× No keyword cloud information.
  4 in total

1.  The Indian langur: preliminary report of a new nonhuman primate host for visceral leishmaniasis.

Authors:  R Pal; K Zehra; J C Katiyar; N Sethi; G Bhatia; R K Singh
Journal:  Bull World Health Organ       Date:  1992       Impact factor: 9.408

Review 2.  Visceral leishmaniasis treatment: What do we have, what do we need and how to deliver it?

Authors:  Lucio H Freitas-Junior; Eric Chatelain; Helena Andrade Kim; Jair L Siqueira-Neto
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-01-28       Impact factor: 4.077

Review 3.  Visceral leishmaniasis: experimental models for drug discovery.

Authors:  Suman Gupta
Journal:  Indian J Med Res       Date:  2011-01       Impact factor: 2.375

4.  Evaluation of a Novel Herbal Immunomodulator Drug (IMOD) in Treatment of Experimental Canine Visceral leishmaniasis.

Authors:  Abdolali Malmasi; Bijan Ziaie Ardestani; Mehdi Mohebali; Behnaz Akhoundi; Shadi Ziaie; Majid Masoudifard; Hamidreza Khorram Khorshid; Mehdi Nasiri; Saeed Bayanolhagh; Ehsan Mostafavi; Moin Delrobai; Vahid Siavashi
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.